Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors

NCT06621563 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Non-Small Cell Lung Cancer
Colorectal Cancer

Interventions

DRUG: HS-20117 combined HS-20093
DRUG: HS-20117 combined Platinum-containing chemotherapy
DRUG: HS-20117 combined HS-20093 and 5-FU
DRUG: HS-20117+CAPEOX
DRUG: HS-20117+FOLFIRI
DRUG: HS-20117+mFOLFOX6

Sponsor

Hansoh BioMedical R&D Company